Compare VICR & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICR | ALGN |
|---|---|---|
| Founded | 1981 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 10.5B |
| IPO Year | 1995 | 2000 |
| Metric | VICR | ALGN |
|---|---|---|
| Price | $159.21 | $168.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $390.00 | $185.79 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 10-20-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1764.29 | 0.53 |
| EPS | 2.81 | ★ 4.98 |
| Revenue | ★ $452,701,000.00 | $387,126,000.00 |
| Revenue This Year | $57.49 | $2.24 |
| Revenue Next Year | $46.87 | $2.86 |
| P/E Ratio | $58.41 | ★ $33.59 |
| Revenue Growth | ★ 26.08 | 23.95 |
| 52 Week Low | $80.29 | $130.23 |
| 52 Week High | $382.65 | $200.44 |
| Indicator | VICR | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 38.85 | 62.33 |
| Support Level | $130.85 | $164.75 |
| Resistance Level | $205.69 | $183.23 |
| Average True Range (ATR) | 14.21 | 6.51 |
| MACD | -0.36 | 1.56 |
| Stochastic Oscillator | 30.28 | 75.56 |
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. The principal markets for the Company's power converters and systems are large original equipment manufacturers (OEMs), original design manufacturers (ODMs) and their contract manufacturers, and smaller, lower volume users, which are broadly distributed across several market areas.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.